Remed Reports Modification of Stock-Backed Loan Agreement by Major Shareholder Lee Geun-yong
Major shareholder Lee Geun-yong has modified the terms of his stock-backed loan agreement, with no change to his total shareholding.
AI comment
The disclosure confirms that major shareholder Lee Geun-yong has adjusted the terms of existing stock-backed loan agreements. Crucially, the total number of shares held remains unchanged at 11,166,576, representing a 36.88% stake in the company. Because the filing does not disclose the specific financial terms of the loan modification—such as the loan-to-value ratio, interest rates, or maturity dates—it is impossible to assess whether this change reflects improved liquidity or increased financial pressure on the shareholder. This is a procedural update regarding the collateral structure of the existing holdings rather than a change in ownership. Consequently, the market impact is negligible as there is no actual shift in the supply of shares or the controlling interest.
Market data
리메드 · 302550 · KOSDAQ →Previous-close data, updated T+1 · Source: Financial Services Commission of Korea via data.go.kr
Key takeaway
"Remed Reports Modification of Stock-Backed Loan Agreement by Major Shareholder Lee Geun-yong" — BullBear's AI rates this story as a mixed, direction-neutral signal, with a market-impact score of 20 out of 100. That score reflects how strongly the story is likely to move Bitcoin, US equities, the dollar, and gold, and near-duplicate coverage of the same event is clustered so only the representative article is scored. Reported by 금융감독원 전자공시(DART) on September 09, 2026. The call is verified against the actual 24-hour price move on BullBear's public conviction ledger.
Get the next high-impact catalyst
Telegram alerts when our AI scores a story 80+/100 impact (~1-3 per day, no spam). Verified 30d hit rate 45.2%.